Rapibloc 300 mg Pulver zur Herstellung einer Infusionslösung

DRUG2 trials

Sponsors

Medical University Of Vienna

Conditions

Beta-blocker intakeNormal left ventricular ejection fractionST-elevation acute coronary syndromeSinus rhythm

Phase 3

A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery

RecruitingCTIS2024-518950-17-00

Medical University Of ViennaBeta-blocker intake, Normal left ventricular ejection fraction, Sinus rhythm

Start: 2021-10-18Target: 164Updated: 2025-01-27

Phase 4

The effect of early Landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention – A prospective, randomized, double- blinded, placebo controlled, phase IV pilot trial (STEMILAND-1)

Not yet recruitingCTIS2025-523676-23-00

Medical University Of ViennaST-elevation acute coronary syndrome

Target: 60Updated: 2025-12-14